Liven Pharmaceuticals Limited (PSX: LIVEN)

Liven Pharmaceuticals Cash Flow Statement

Financials in millions PKR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Net Income	139.96	-11.18	-12.33	-14.29	-14.63	-16.93
Depreciation & Amortization	8.52	11.79	13.1	14.56	16.08	17.87
Other Operating Activities	-64.55	-2.61	-2.9	-3.22	-3.55	-3.09
Change in Accounts Payable	-	-	-	-0.07	-4.16	-
Change in Other Net Operating Assets	0.82	1.12	-0.14	0.76	-0.52	0.26
Operating Cash Flow	-0.68	-0.88	-2.27	-2.26	-6.79	-1.89
Short-Term Debt Issued	-	0.89	2.27	2.24	6.79	1.91
Total Debt Issued	0.26	0.89	2.27	2.24	6.79	1.91
Net Debt Issued (Repaid)	-204.38	0.89	2.27	2.24	6.79	1.91
Financing Cash Flow	-204.38	0.89	2.27	2.24	6.79	1.91
Net Cash Flow	29.32	0.01	0	-0.02	-0.01	0.03
Free Cash Flow	-0.68	-0.88	-2.27	-2.26	-6.79	-1.89
Free Cash Flow Per Share	-0.02	-0.07	-0.19	-0.19	-0.56	-0.16
Levered Free Cash Flow	-219.86	4.29	3.45	4.31	0.03	9.85
Unlevered Free Cash Flow	-219.86	4.29	3.45	4.31	0.03	9.85
Change in Net Working Capital	234.88	-1.12	0.14	-0.7	4.69	-4.49

Source: S&P Capital IQ. Standard template. Financial Sources.